**Core Concept**
Limited cutaneous scleroderma is a subtype of systemic sclerosis characterized by skin thickening and fibrosis primarily affecting the hands, face, and lower extremities. This condition can lead to various systemic complications, including pulmonary involvement.

**Why the Correct Answer is Right**
The patient's complaint of shortness of breath in the context of limited cutaneous scleroderma suggests pulmonary involvement. The most likely diagnosis is pulmonary fibrosis, a common complication of systemic sclerosis. Pulmonary fibrosis is characterized by the scarring of lung tissue, leading to impaired gas exchange and shortness of breath. The pathophysiology involves the activation of fibroblasts, leading to the excessive production of collagen and other extracellular matrix proteins, resulting in fibrosis and lung stiffness.

**Why Each Wrong Option is Incorrect**
**Option A:** Pulmonary embolism is an acute condition typically presenting with sudden onset of dyspnea, chest pain, and possibly syncope. It is not directly related to the chronic progression of limited cutaneous scleroderma.
**Option B:** Heart failure is a common cause of shortness of breath but would not be directly related to the underlying skin manifestations of limited cutaneous scleroderma.
**Option C:** Asthma is a chronic inflammatory disease of the airways, but it would not be the primary diagnosis in this patient with a known history of limited cutaneous scleroderma and progressive shortness of breath.

**Clinical Pearl / High-Yield Fact**
Pulmonary fibrosis in systemic sclerosis can be diagnosed using high-resolution computed tomography (HRCT) of the chest, which shows characteristic findings such as honeycombing, traction bronchiectasis, and ground-glass opacifications.

**Correct Answer:** C. Pulmonary fibrosis